EUVIMEDEUVIMED entdecken
Fallbericht

Four‐month‐old with severe PIK3CA ‐related overgrowth spectrum disorder successfully treated with alpelisb

María-Laura Cossio iD, Josefina Rodríguez, Juan Carlos Flores, Florencia De Barbieri, Álvaro Flores, José Marín, Carla Florin, Francisco Cuevas, Monserrat Gutiérrez

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15582 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von María-Laura Cossio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Thiazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIK3CA ‐related overgrowth spectrum (PROS) encompasses different clinical entities caused by somatic activating mutations in PIK3CA . Among PROS, CLOVES syndrome represents a severe phenotype with poor survival rate. We present the case of a 4‐month‐old girl with CLOVES syndrome successfully treated with alpelisib, a PIKC3A inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class I Phosphatidylinositol 3-KinasesThiazolesHumansFemaleInfantVascular MalformationsNephrocalcinosisMutationLipomaMusculoskeletal AbnormalitiesNevus

Stichwörter der Autor:innen

pharmacotherapyvascular anomaliesvascular malformations

Substanzen

Class I Phosphatidylinositol 3-KinasesPIK3CA protein, humanAlpelisibThiazoles

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Dermatology, Hospital Dr. Sótero del Río, Santiago, Chile.
  • Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Pediatrics, Hospital Dr. Sótero del Río, Santiago, Chile.
  • Department of Radiology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Pediatric Radiology, Hospital Dr. Sótero del Río, Santiago, Chile.

ORCID-Profile: María-Laura Cossio

Zitieren

APA

Cossio, M. L., Rodríguez, J., Flores, J. C., De Barbieri, F., Flores, Á., Marín, J., Florin, C., Cuevas, F., & Gutiérrez, M. (2024). Four‐month‐old with severe PIK3CA ‐related overgrowth spectrum disorder successfully treated with alpelisb. Pediatric Dermatology. https://doi.org/10.1111/pde.15582

Vancouver

Cossio ML, Rodríguez J, Flores JC, De Barbieri F, Flores Á, Marín J, et al. Four‐month‐old with severe PIK3CA ‐related overgrowth spectrum disorder successfully treated with alpelisb. Pediatric Dermatology. 2024. doi:10.1111/pde.15582

BibTeX
@article{Cossio2024,
  author = {Cossio, María-Laura and Rodríguez, Josefina and Flores, Juan Carlos and De Barbieri, Florencia and Flores, Álvaro and Marín, José and Florin, Carla and Cuevas, Francisco and Gutiérrez, Monserrat},
  title = {Four‐month‐old with severe PIK3CA ‐related overgrowth spectrum disorder successfully treated with alpelisb},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15582}
}
Kostenlos starten →